Registry of multicenter clinical trials. Eleventh report--1989.

Ce rapport annuel presente des essais multicentres, faits a part et controles, dans les domaines de thrombose, hemostase et l'atherosclerose. L'enregistrement des essais cliniques encourage la collaboration et la communication entre investigateurs concernant les essais nouveaux ou en cours, il fournit une base pour la recherche methodologique et facilite les metaanalyses par la validite d'un systeme d'identification d'essais qui est independant de la litterature publiee

[1]  Final report on the aspirin component of the ongoing Physicians' Health Study. , 1989, The New England journal of medicine.

[2]  P. Waller,et al.  Drug treatment of intermittent claudication: a critical analysis of the methods and findings of published clinical trials, 1965-1985. , 1988, British journal of clinical pharmacology.

[3]  K. Dickersin.  Report from the panel on the Case for Registers of Clinical Trials at the Eighth Annual Meeting of the Society for Clinical Trials. , 1988, Controlled clinical trials.

[4]  R. Doll,et al.  Randomised trial of prophylactic daily aspirin in British male doctors , 1988, British medical journal.

[5]  G. Clagett.  Drug-induced inhibition of platelet function delays progression of peripheral occlusive arterial disease: A prospective double-blind arteriographically controlled trial , 1985 .

[6]  J L Ritchie,et al.  The western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. A 12-month follow-up report. , 1985, The New England journal of medicine.

[7]  H. S. Mueller,et al.  The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.

[8]  K. Karsch,et al.  Effects of intracoronary streptokinase and intracoronary nitroglycerin infusion on coronary angiographic patterns and mortality in patients with acute myocardial infarction. , 1984, The New England journal of medicine.

[9]  S. Wacholder,et al.  The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery. , 1984, The New England journal of medicine.

[10]  M. Verstraete.  Registry of Prospective Clinical Trials - Sixth Report , 1984, Thrombosis and Haemostasis.

[11]  E. Loeliger.  Oral anticoagulation in patients surviving myocardial infarction. A new approach to old data. , 1984, European journal of clinical pharmacology.

[12]  Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. , 1984, The New England journal of medicine.

[13]  V. Fuster,et al.  A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency. , 1982, The New England journal of medicine.

[14]  M. Verstraete.  Registry of Prospective Clinical Trials - Fifth Report , 1982, Thrombosis and Haemostasis.

[15]  G. Hutchins,et al.  Accelerated “Atherosclerosis” A Morphologic Study of 97 Saphenous Vein Coronary Artery Bypass Grafts: A Morphologic Study of 97 Saphenous Vein Coronary Artery Bypass Grafts , 1977, Circulation.

[16]  M. Verstraete.  Registry of Prospective Clinical Trials Second Report , 1976, Thrombosis and Haemostasis.

[17]  M. Verstraete.  Registry of prospective clinical trials second report. , 1976, Thrombosis and haemostasis.

[18]  M. Verstraete.  Registry of Prospective Clinical Trials , 1975, Thrombosis and Haemostasis.